The newly diagnosed ITP group showed significantly higher values of caspase 3, caspase 8 and BCL2 in the pretreatment state than the post treatment state (P = 0.01, < 0.001 and 0.034, respectively) (Table 3). The gene discussed is CASP3; the disease is autoimmune thrombocytopenic purpura.